Boiron is expanding its Arnicare line of Arnica-based pain relievers—and launching Arnicare Arthritis Cream.

It provides temporary relief of minor joint pain, muscle pain, and stiffness due to arthritis. It is one of the first arthritis topical medicines containing Harpagophytum (devil’s claw) available in the U.S. by a major brand. Boiron is a world leading global company in homeopathic medicines.

“As a health-driven company, we have always prioritized innovation in our over-the-counter offerings,” says Ron Gentry, vice president of Marketing, Boiron USA. “We are excited to bring Arnicare Arthritis Cream to the market as an affordable and alternative pain relief option for the millions of Americans living with arthritis. Harpagophytum has demonstrated its versatility and utility in the joint supplement space, and our homeopathic medicine now brings this ingredient to the OTC world.”

Powered by plant-based pain relievers, Arnicare Arthritis Cream contains Arnica montana and Harpagophytum to target multiple symptoms of minor arthritis pain.

Arnica montana, a mountain daisy, is one of the most popular homeopathic medicines used worldwide for muscle pain, stiffness, and bruising. Harpagophytum, commonly known as devil’s claw with wide herbal use in Europe, relieves joint discomfort and stiffness associated with arthritis pain.

Arnicare Arthritis Cream is formulated to absorb quickly, and can be applied to all joints to address minor arthritis pain in the hands, hips, knees, feet, and lower back. The cream is also fragrance-free and does not contain camphor, menthol, and other counterirritants that can burn or sting the skin. It is packaged in a tube.